RT @csiskind: The addition of Wilson's disease brings the ACMG 59 recommended genes into the #neuroGC realm. #ATP7B https://t.co/3zg39s8To6
RT @gcleslieb: .@TheACMG updated recommendations for reporting secondary findings, incl. addition of SMAD4/BMPR1A, others: https://t.co/pVH…
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
ACMG reports on secondary findings re: clinical exome and genome sequencing reporting - https://t.co/p6gGydUpZY
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
Como siempre la ACMG (@TheACMG) guiándonos en cómo mejorar nuestro trabajo como genetistas con las tecnologías más modernas https://t.co/7Ir3pRV9X3
RT @GIMJournal: Find @TheACMG new recommendations for reporting secondary findings in @GIMJournal https://t.co/Y3WNEKXdWB
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
Revised #secondary #findings list from @TheACMG. #genomics. Of interest to @jacquie_savard and @lisadive https://t.co/v8zdiWFVnB
Nice to PGX entering the discussion formally too. https://t.co/FTHRV7wPQs
RT @CarrieBlout: The ACMG 56 is now the ACMG 59 authored by our own @SarahKaliaGC! https://t.co/mk0CKuwCu0 #GCchat @GeneticCouns @Genomes2P…
RT @GeisingerADMI: Congrats to ADMI's @clesemartin, co-chair of the Secondary Findings Working Group! https://t.co/4GXkgtDV9X
RT @GeisingerADMI: Congrats to ADMI's @clesemartin, co-chair of the Secondary Findings Working Group! https://t.co/4GXkgtDV9X
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
RT @kdchrist: The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
From ACMG56 to ACMG59! Recommendations for 59 medically actionable genes to be returned in genomic seq @GIMJournal https://t.co/qCfgoc5eyl
@SarahKaliaGC 1st author of updated @TheACMG recommendations for reporting secondary findings f/ #genome sequencing! @GeneticCouns #GCchat https://t.co/SWNnQjJrVJ
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
RT @csiskind: The addition of Wilson's disease brings the ACMG 59 recommended genes into the #neuroGC realm. #ATP7B https://t.co/3zg39s8To6
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
RT @RobertCGreen: ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's no…
ACMG secondary findings recommendations 2.0 add BMPR1A, SMAD4, ATP7B, OTC & discard MYLK https://t.co/l1NS5xq4Y9 It's now the ACMG59 !
RT @csiskind: The addition of Wilson's disease brings the ACMG 59 recommended genes into the #neuroGC realm. #ATP7B https://t.co/3zg39s8To6
ACMG59 just doesn't roll off the tongue quite as well as ACMG56. https://t.co/lkiesL7ijA
Updated ACMG list of gene variants to report as incidental (secondary) findings in clinical genome sequencing ... https://t.co/p5CMicl7uM
RT @CarrieBlout: The ACMG 56 is now the ACMG 59 authored by our own @SarahKaliaGC! https://t.co/mk0CKuwCu0 #GCchat @GeneticCouns @Genomes2P…
RT @moorejh: MT @TheACMG ACMG Releases New Recommendations for Reporting Secondary Findings in Clinical #Genomics Sequencing https://t.co/r…
The addition of Wilson's disease brings the ACMG 59 recommended genes into the #neuroGC realm. #ATP7B https://t.co/3zg39s8To6
RT @GIMJournal: Find @TheACMG new recommendations for reporting secondary findings in @GIMJournal https://t.co/Y3WNEKXdWB
Updated ACMG "clinically actionable" gene list, now with 59 genes! https://t.co/wSfUAAYI31
RT @gcleslieb: .@TheACMG updated recommendations for reporting secondary findings, incl. addition of SMAD4/BMPR1A, others: https://t.co/pVH…
RT @CarrieBlout: The ACMG 56 is now the ACMG 59 authored by our own @SarahKaliaGC! https://t.co/mk0CKuwCu0 #GCchat @GeneticCouns @Genomes2P…
RT @gcleslieb: .@TheACMG updated recommendations for reporting secondary findings, incl. addition of SMAD4/BMPR1A, others: https://t.co/pVH…
RT @GIMJournal: Find @TheACMG new recommendations for reporting secondary findings in @GIMJournal https://t.co/Y3WNEKXdWB
RT @moorejh: MT @TheACMG ACMG Releases New Recommendations for Reporting Secondary Findings in Clinical #Genomics Sequencing https://t.co/r…
.@TheACMG updated recommendations for reporting secondary findings, incl. addition of SMAD4/BMPR1A, others: https://t.co/pVHmcpUpB9 #GCchat
RT @kdchrist: The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
RT @GeisingerADMI: Congrats to ADMI's @clesemartin, co-chair of the Secondary Findings Working Group! https://t.co/4GXkgtDV9X
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
RT @MichelleNMeyer: ATP7B, BMPR1A, SMAD4 & OTC join the club; MYLK is voted off the island, & PTCH1 fails to make the cut. https://t.co/XCg…
RT @moorejh: MT @TheACMG ACMG Releases New Recommendations for Reporting Secondary Findings in Clinical #Genomics Sequencing https://t.co/r…
RT @GeisingerADMI: Congrats to ADMI's @clesemartin, co-chair of the Secondary Findings Working Group! https://t.co/4GXkgtDV9X
Congrats to ADMI's @clesemartin, co-chair of the Secondary Findings Working Group! https://t.co/4GXkgtDV9X
Watch this space: @TheACMG SF v2.0 is likely the first of many updates to the #ActionableGenome: https://t.co/BwlLkamtVu #genome #PGx
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
The ACMG 56 is now the ACMG 59 authored by our own @SarahKaliaGC! https://t.co/mk0CKuwCu0 #GCchat @GeneticCouns @Genomes2People
ATP7B, BMPR1A, SMAD4 & OTC join the club; MYLK is voted off the island, & PTCH1 fails to make the cut. https://t.co/XCgIIVRSiZ
#ELSI issues are mentioned throughout! #genetics #ethics https://t.co/O2UmzH0dbm
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
RT @kdchrist: The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
RT @cvgenetics: One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disea…
MT @TheACMG ACMG Releases New Recommendations for Reporting Secondary Findings in Clinical #Genomics Sequencing https://t.co/rtgjyuCyqZ
RT @GIMJournal: Find @TheACMG new recommendations for reporting secondary findings in @GIMJournal https://t.co/Y3WNEKXdWB
One cardiovascular disease gene removed from the ACMG list: MYLK (thoracic aortic aneurysm and dissection) No new cv disease genes added https://t.co/ojp101Ljev
RT @kdchrist: The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
RT @kdchrist: The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
The "ACMG 56" is now the "ACMG 59"! Nice job, @SarahKaliaGC @Genomes2People https://t.co/o4BgBkDysd
Find @TheACMG new recommendations for reporting secondary findings in @GIMJournal https://t.co/Y3WNEKXdWB
RT @hail_CSER: @TheACMG SF v2.0: Recommendations for reporting of SF in clinical exome and genome sequencing 2016 update https://t.co/nn8ZS…